SPC
CRMD icon

Sigma Planning Corp’s CorMedix CRMD Stock Holding History

Sigma Planning Corp’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Sell
29,611
-5,309
-15% -$41.9K 0.01% 1242
2026
Q1 		$237K Buy
34,920
+11,048
+46% +$81.7K 0.01% 1154
2025
Q4 		$278K Sell
23,872
-2,759
-10% -$30.5K 0.01% 1069
2025
Q3 		$310K Sell
26,631
-737
-3% -$8.91K 0.01% 1024
2025
Q2 		$337K Sell
27,368
-8,937
-25% -$98.7K 0.01% 950
2025
Q1 		$224K Buy
36,305
+2,612
+8% +$27K 0.01% 1080
2024
Q4 		$273K Sell
33,693
-6,254
-16% -$62.5K 0.01% 968
2024
Q3 		$323K Buy
39,947
+7,679
+24% +$41.6K 0.01% 931
2024
Q2 		$140K Buy
32,268
+944
+3% +$4.8K ﹤0.01% 1120
2024
Q1 		$133K Buy
+31,324
New +$109K ﹤0.01% 1169

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Sigma Planning Corp's CRMD Position: Q2 2026 in Review

Sigma Planning Corp reduced its CorMedix (CRMD) stake by 15% in Q2 2026, selling an estimated $41.9K and leaving 29,611 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #1242.

Sigma Planning Corp first reported a position in CRMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $337K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Sigma Planning Corp held 29,611 shares of CorMedix worth $232K as of Q2 2026.
  • Sigma Planning Corp sold 5,309 CorMedix shares in Q2 2026, an estimated $41.9K.
  • CorMedix made up 0.01% of Sigma Planning Corp's portfolio in Q2 2026, its #1242 holding.
  • Sigma Planning Corp first reported a position in CorMedix in Q1 2024 and has held it in 10 quarters since.
  • Sigma Planning Corp's CorMedix position peaked at $337K in Q2 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Sigma Planning Corp's 13F filing for Q2 2026, filed 7 Aug 2026.